Earningsreport

Q2/2023 6/30/2023 EPS -0.140 ZacksConsensus -0.130 ActVsEst (0.010) - Miss

VolitionRX Limited  (VNRX) 
NASDAQ:AMEX Investor Relations: ir.volitionrx.com